DPDiah Puspitosari

Diah Puspitosari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diah Puspitosari has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anogenital Warts in an Elderly Male: Clinical and Public Health Perspectives

    by Pati Aji Achdiat, Rifqy Wahyu Mochamad Ihsan, Laila Tsaqilah, Oki Suwarsa, Diah Puspitosari, Debora Natalia Ndaparoka, Retno Hesty Maharani

    Anogenital warts (AGWS), caused by human papillomavirus (HPV), are among the most common sexually transmitted infections (STIs). Although AGWS is more commonly found in younger adults, cases in older individuals are increasingly being reported. A 76-year-old man presented with progressively enlarging brown papules in the genital area (penile base, scrotum, and left inguinal fold). Histopathological examination showed epidermal hyperplasia, papillomatosis, acanthosis, and koilocytosis. PCR examination confirmed low-risk HPV types 6 and 11. The patient reported a history of multiple sexual partners, did not use condoms during sexual intercourse, and had limited knowledge regarding STIs transmission based on a questionnaire. The patient was treated with cryotherapy and lesion excision. At the final observation, complete lesion resolution was achieved with no new lesions observed. In conclusion, this case highlights the importance of maintaining clinical awareness of AGWs in older adults. Thorough diagnostic evaluation, sexual health education, regular STIs screening, and counseling should be integrated into routine care for the elderly population.

  • Open Access

    Combination of Hyaluronic Acid and Polynucleotides Injection for the Treatment of Cheilitis Simplex

    by Kartika Ruchiatan, Yuri Yogya, Ilma Arifani, Reti Hindritiani, Diah Puspitosari, Trustia Rizqandaru, Srie Gondokaryono, Pati Achdiat

    Cheilitis simplex is a prevalent form of cheilitis that is characterized by the presence of cracked lips, fissures, or desquamation, due to various etiologies. Utilization of “boosters” as a treatment for chapped lips has not been extensively researched. This case report aimed to describe the efficacy of lip booster injection comprising active ingredients of 1% hyaluronic acid (HA) and 1% polynucleotides (PN), with 0.3% lidocaine as anesthetic agent. A 30-year-old female patient presented with a chief complaint of dry and chapped lips that occasionally bleed. This condition had recently deteriorated, and the application of topical treatment had not yielded substantial improvement, which led to a state of distress for the patient. She was diagnosed with cheilitis simplex and was subsequently treated with a single subdermal injection of a combination of 1% HA, 1% PN, and 0.3% lidocaine. Lip hydration was increased gradually, as measured by tewameter, with peak rate of hydration (26.218 g/m2/h) occurred two weeks after injection, and subsequently decreased gradually until six weeks after injection (29.926 g/m2/h); however, the rate of hydration remained higher than the baseline value (34.386 g/m2/h). Additionally, the lips exhibited an increase in brightness and a shift in pigmentation toward a rosier hue, as substantiated by spectrophotometric analysis. The mechanism of HA and PN include providing hydration and stimulating dermal fibroblast activity. However, PN may also exert an additional effect of improving lip pigmentation by reducing melanin and increasing hemoglobin levels. In conclusion, the lip booster injection, comprising 1% PN, 1% non-cross-linked HA, and 0.3% lidocaine, is an efficacious and practical treatment option for cheilitis simplex. This treatment option offers the additional benefits of being pain-free and enhancing lip pigmentation. Further studies are required to confirm these findings.


  • Open Access

    The Comparable Efficacy Between Tranexamic Acid Intradermal Injection and Pulsed Dye Laser for Treatment of Post-Acne Erythema: A Split-Face Therapy

    by Kartika Ruchiatan, Gempita Nuzuliyah, Trustia Rizqandaru, Yuri Yogya, Diah Puspitosari, Miranti Pangastuti, Rafithia Anandita, Reti Hindritiani

    Post-acne erythema (PAE) is persistent erythema after acne vulgaris (AV) inflammatory lesions have resolved. Pulsed dye laser (PDL) is the gold standard for vascular lesions and is effective for PAE. Tranexamic acid (TA) can reduce vascular endothelial growth, angiogenesis, and inflammation by inhibiting plasminogen activity, and can be used in PAE treatment. This case report aim to compare the clinical efficacy of intradermal TA and PDL therapy using a split-face design in a 23-year-old female with moderate AV, post-inflammatory hyperpigmentation (PIH), and PEA. Dermatological examination revealed comedones, papules, pustules, nodules, hyperpigmented macules, boxcar scars, and erythematous macules overlying the post-acne atrophic scars. In addition to acne therapy, patient received intradermal TA (5 mg/mL) on the left face and PDL therapy on the right, respectively. Outcomes were assessed at day 7 and day 14. Parameters evaluated included acne lesion count, erythema index (a* value), and Dermatology Life Quality Index (DLQI). Both interventions led to a comparable result as such decreased a* value by 17.8% on the TA-treated side and 16% on the PDL-treated side. The DLQI score also improved. Both treatment modalities are effective for PAE and repeated sessions are necessary to achieve optimal results. Intradermal TA demonstrates comparable short-term efficacy to PDL in reducing PAE and may represent a safe, cost-effective alternative, particularly in resource-limited settings. Further studies with larger cohorts are needed to validate these findings.


  • Open Access

    Pure Neuritic Leprosy In Children With Grade 2 Disability On Hands And Feet: A Rare Case And Literature Review

    by Hendra Gunawan, Kartika Ruchiatan, Diah Puspitosari, Reti Hindritiani, Hermin Aminah Usman, Stephanie Widjaja

    Pure neuritic leprosy (PNL) is a rare clinical variant of leprosy, especially in children. This variant of leprosy only involves peripheral nerves without skin involvement or acid-fast bacilli (AFB) found on slit-skin smear examination. The challenging diagnosis and establishment of PNL due to the absence of skin lesions often lead to disability. A case of PNL with grade 2 disability of hands and feet in a 16-year-old boy was reported. The patient has been living in a leprosy-endemic area and has a history of contact with people who have symptoms of leprosy. On physical examination, there were finger contractures on both hands and feet, accompanied by bilateral ulnar, common peroneal, and posterior tibial nerve enlargement without any skin lesions. No AFB was found on the slit-skin smear examination. The diagnosis of PNL was established by the mononeuritis multiplex detected on the nerve conduction examination and the histopathological examine from the biopsy of the left ulnar nerve, which showed lymphocyte infiltration. The patient was treated with multidrug therapy for multibacillary leprosy and consulted with the Department of Physical Medicine and Rehabilitation and the Department of Orthopaedics and Traumatology for contracture management. Clinicians need to be aware of the signs and symptoms of PNL in order to avoid delays in diagnosis and treatment, as the diagnosis and establishment of PNL remain challenging.


  • Open Access

    A Review and Case Study of Genital and Extragenital Human Papillomavirus Type 6 and 11 Infections in Men Who Have Sex with Men Accompanied by Human Immunodeficiency Virus Infection

    by Pati Aji Achdiat, Rita Septharina, Rasmia Rowawi, Hartati Purbo Dharmadji, Diah Puspitosari, Hermin Aminah Usman, Retno Hesty Maharani

    Extragenital warts caused by HPV types 6 and 11 are rarely reported. However, major risk factors for anogenital warts (AGW) include men who have sex with men (MSM) and Human Immunodeficiency Virus (HIV) infection. The incidence of extragenital warts among these populations has not been reported. This study presented a case report of a 33-year-old male with high-risk sexual behavior who showed symptoms of flesh-colored and hyperpigmentation papules. Furthermore, verrucous surfaces were observed at genital and extragenital. The patient had a history of using the same razor for pubic and armpit hair, bathing with a mesh scrub, and scratching the anal area. The histopathological result showed koilocytes, while polymerase chain reaction (PCR) examination for both genital and extragenital lesions confirmed HPV type 6 and 11. This represented the first reported case describing the incidence of extragenital and AGW caused by HPV types 6 and 11. The transmission of extragenital warts was facilitated through fomites autoinoculation, particularly in the immunocompromised condition induced by HIV, which was common among MSM. Extragenital warty-like lesions were considered as warts caused by HPV type 6/11, in HIV-infected persons, specifically MSM.


  • Open Access

    Partial Unilateral Lentiginosis Successfully Treated with the Combination of 511 nm and 578 nm Copper Bromide Laser in an Indonesian Woman

    by Reti Hindritiani, Muhamad Radyn Haryadi Widjaya, Diah Puspitosari, Trustia Rizqandaru, Kartika Ruchiatan

    Partial unilateral lentiginosis (PUL) is a pigmentation disorder characterized by multiple lentigines restricted to the normal skin in a unilateral and segmental pattern. Various lasers have been used for the treatment of this pigmented disorders, one of which is the copper bromide (CuBr) laser, which emits a dual-wavelength beam at 511 nm and 578 nm. A 35-year-old woman presented with multiple brown macules with a sharp demarcation from the midline of the forehead to the right cheek in a dermatomal distribution. Histopathological results showed increased melanin pigmentation in the basal layer with elongated rete ridges, supporting the diagnosis of PUL. Following photoprotection and skin priming, CuBr laser treatment was performed in two steps using 511 nm and 578 nm wavelength as the first and second steps, respectively, with the second step delivered immediately after. Clinical improvement was achieved after two sessions of treatment at a one-month interval, as shown by an increasing lightness value (L*) in spectrophotometry. No side effects, such as hyperpigmented macules, was observed. The patient also expressed satisfaction at her brighter facial skin. A sustainable favorable result persisted after six months of laser treatment. Interactions between cutaneous vasculature and melanocytes can affect the development of pigmented lesions. Melanocytes express the functional vascular endothelial growth factor receptor (VEGF) and are responsive to angiogenic factors. Ideally, these conditions should be treated with a dual-wavelength CuBr laser. The combination of 511 nm and 578 nm CuBr laser showed favorable results, supporting its potential as an effective treatment choice for PUL.


  • Open Access

    Treatment of Facial Lentigines in an Adult Female Patient Suspected with Leopard Overlap Noonan Syndrome

    by Kartika Ruchiatan, Noer Olivy Alifiar, Diah Puspitosari, Reti Hindritiani

    Lentigines are defined as multiple small pigmented macules measuring up to one centimeter and surrounded by normal-appearing skin, commonly caused by genetic factors. LEOPARD syndrome (LS) is an autosomal dominant distinguished by the presence of several lentigines, with specific phenotypic characteristics that resembles Noonan syndrome (NS). LS is likely to be underdiagnosed or misdiagnosed because many of its symptoms are minor and the accurate diagnosis may be overlooked. Therapy for lentigines are generally aimed at tackling aesthetic disfigurement and its subsequent psychological impacts. This case report aims to highlight the efficacy of 532-nanometer (nm) Q-switched (QS) Nd:YAG laser in treating lentigines in a 21-year-old woman with LS overlap NS. The patient initially came to seek treatment of her facial lentigines. However, some mild abnormalities such as ocular hypertelorism, left eye ptosis, and webbed neck were observed. Hormonal, cardiac, and pulmonary functions were within normal limit. Histopathological results supported the diagnosis of lentigo. The patient was given sunscreen and depigmenting agents and was instructed to apply the medications routinely. The patient then underwent two sessions of 532-nm QS Nd:YAG laser with a 3 mm spot size, 1 J/cm2 fluence, and a 1 Hz frequency. Objective clinical improvements were observed using spectrophotometer examination, there were no side effects found, and she was satisfied with the results. Dermatologists should play an integral role in establishing the diagnosis and management of systemic syndrome, manifesting specifically as dermatological symptoms. Lentigines in LS last throughout the patient’s lifespan. Nd:YAG laser therapy can be effective in treating lentigines with long-lasting results. It plays a role in improving the patient’s life quality, especially where the genetic disorder itself is a debilitating condition. The limitation of this case report was the lack of a genetic test, as the suspected diagnosis was made based on clinical symptoms.


  • Open Access

    Combination of 1064 nm Long-Pulsed and Q-Switched Nd:YAG Laser for Facial Hypertrophic Scar and Hyperpigmentation Following Burn Injury

    by Kartika Ruchiatan, Kamelia Utami Suhada, Reti Hindritiani, Diah Puspitosari, Rani Septrina

    Burn injury is a common type of trauma which causes significant morbidity and mortality. Wound healing following burns can be complicated by the formation of hypertrophic scars and the occurrence of post-inflammatory hyperpigmentation (PIH). Neodymium:yttrium aluminum garnet (Nd:YAG) laser might become one of the treatments of choice for hypertrophic scars and PIH. We report a case of post-burn hypertrophic scars and hyperpigmentation in a 20-year-old man. The patient was consulted from the Department of Plastic Surgery and Reconstruction after scar revision. He was treated with 1064 nm long-pulsed Nd:YAG laser therapy, spot size 6 mm, fluence 55 J/cm2, pulse duration 3 millisecond (ms), for three sessions with one month interval, followed by 1064 nm Q-switched (QS) Nd:YAG, spot size 4 mm, fluence 2.5 J/cm2, frequency 2 Hz for two sessions with one month interval. Clinical improvement was observed after five sessions, characterized by scar thinning as assessed using Vancouver scar scale and increased skin tone brightness also reduced redness assessed using a spectrophotometer with no significant side effects. The management of post-burn facial scars and hyperpigmentation remains a challenge. Aside from surgery, the treatment strategy for hypertrophic scar is laser, one of which is the long-pulsed Nd:YAG laser which reduces the production of collagen. In hyperpigmented lesions, QS Nd:YAG laser destructs the melanosome. Combination of 1064 nm long-pulsed and QS Nd:YAG laser therapy provide significant improvement. These therapeutic strategies can be considered as a treatment option for post-burn hypertrophic scars and hyperpigmentation.


  • Open Access

    Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil

    by Kartika Ruchiatan, Erda Avriyanti, Reti Hindritiani, Diah Puspitosari, Oki Suwarsa, Hendra Gunawan

    Alopecia areata (AA) is an autoimmune disease-specific to specific organs mediated by T lymphocytes with hair follicles as targets. Severe AA could be in the form of alopecia universalis (AU). AU therapy is relatively difficult and challenging with varying outcomes. Herein, we reported a case of AU in a 19-year-old man with alopecia in the hairy scalp area, eyebrows, eyelashes, moustache, beard, and axillary hair since 2.5 years ago. The patient’s severity of alopecia tool (SALT) score was 100%. The patient was given a combination therapy of 15 mg methotrexate per week and 16 mg methylprednisolone per day orally and topical treatment with minoxidil 5%. Observations after nine months of treatment showed an improvement in the decrease in SALT scores to 41%. However, striae were found after 3rd month of therapy. Systemic combination therapy of methotrexate and low-dose corticosteroids and topical minoxidil 5% in this patient gave responsive results. Performed the hematological examination, liver function levels, blood glucose levels, and cortisol during long-term use of methotrexate and corticosteroids are necessary. The combination of systemic methotrexate and corticosteroids, and topical minoxidil showed promising results in AU. Nevertheless, long-term observation is still needed to monitor the side effects of therapy.


  • Open Access

    Hypertrophic Scar Following Excisional Surgery and Full-Thickness Skin Grafting Due to Rhinophyma Treated with 1064 nm Q-Switched Neodymium:Yttrium Aluminum Garnet Laser

    by Kartika Ruchiatan, Reti Hindritiani, Diah Puspitosari, Gabriela Reginata, Rani Septrina

    Rhinophyma is characterized by progressive enlargement of the nasal skin, which is considered to be an advanced stage of phymatous rosacea. Esthetic disfigurement makes surgical treatment necessary for this condition. Hypertrophic scars are the consequence of alterations in the skin’s healing process following surgical interventions. Laser may be the treatment of choice in hypertrophic scars. We reported a case of hypertrophic scars following excisional surgery and full-thickness skin grafting due to rhinophyma in an 18-year-old male who was consulted from the Department of Plastic Surgery and Reconstruction. The 1064 nanometer (nm) Q-switched Neodymium: Yttrium Aluminum Garnet (QS Nd:YAG) with 4 mm spot size, 1.5 J/cm2 and 1 Hz was applied to the hypertrophic scars for three sessions within one month interval. Clinical improvement was observed as indicated by the patient’s Vancouver scar scale score and spectrophotometry result, and no side effects were found. Nd:YAG laser is a non-ablative device that targets hemoglobin, water, and melanin. Any thermal effects on dermal tissue containing blood vessels could result in reduced blood flow through the capillaries in the dermal papillae. QS Nd:YAG-induced selective photothermolysis was responsible for collagen breakdown and reduced collagen production in hypertrophic scars. The 1064 nm QS Nd:YAG laser gave good results in this case although more treatment sessions may be recommended and a longer follow-up is necessary in order to assess the stability of the result.